Abstract
The use and popularity of maggot therapy (MT) – the treatment of wounds with live fly larvae – is increasing rapidly in many countries throughout the world. The advantages of MT, also called larval therapy, maggot debridement therapy (MDT), and biosurgery, include its profound efficacy in debriding necrotic tissue, its relative safety, and its simplicity. These factors, along with other advantages such as its efficiency, its low cost and its effectiveness even in the context of antibiotic-resistant infections, have been responsible for the recent revival in the use of MT.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Angel K, Grassberger M, Huemer F, Stackl W (2000) Maggot therapy in Fournier’s gangrene – first results with a new form of treatment. Aktuelle Urologie 31:440–443
Armstrong DG, Salas P, Short B, Martin BR, Kimbriel HR, Nixon BP, Boulton AJ (2005) Maggot therapy in “lower-extremity hospice” wound care: fewer amputations and more antibiotic-free days. J Am Podiatr Med Assoc 95:254–257
Asociación Mexicana para el Cuidado Integral y Cicatrización de Heridas A.C. [AMCICHAC – Mexican Association for Wound Care and Healing] (2010) Clinical practice guidelines for the treatment of acute and chronic wounds with maggot debridement therapy. http://aawconline.org/wp-content/uploads/2011/09/GPC_larvatherapy.pdf. Last accessed 26 Aug 2012
Baer WS (1929) Sarco-iliac joint-arthritis deformans-viable antiseptic in chronic osteomyelitis. Proc Int Assemb Inter-state Postgrad Med Assoc North Am 371:365–372
Baer WS (1931) The treatment of osteomyelitis with the maggot (larva of the blowfly). J Bone Joint Surg 13:438–475
Barnard DR (1977) Skeletal-muscular mechanisms of the larva of Lucilia sericata (Meigen) in relation to feeding habit. Pan-Pac Entomol 53:223–229
Barnes KM, Gennard DE, Dixon RA (2010) An assessment of the antibacterial activity in larval excretion/secretion of four species of insects recorded in association with corpses, using Lucilia sericata Meigen as the marker species. Bull Entomol Res 100:635–640
Bexfield A, Nigam Y, Thomas S, Ratcliffe NA (2004) Detection and partial characterization of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus (MRSA). Microbes Infect 6:1297–1304
Blake FA, Abromeit N, Bubenheim M, Li L, Schmelzle R (2007) The biosurgical wound debridement: experimental investigation of efficiency and practicability. Wound Repair Regen 15:756–761
Bowling FL, Salgami EV, Boulton AJ (2007) Larval therapy: a novel treatment in eliminating methicillin-resistant Staphylococcus aureus from diabetic foot ulcers. Diabetes Care 30:370–371
Brown A, Horobin A, Blount DG, Hill PJ, English J, Rich A, Williams PM, Pritchard DI (2012) Blow fly Lucilia sericata nuclease digests DNA associated with wound slough/eschar and with Pseudomonas aeruginosa biofilm. Med Vet Entomol 26(4):432–439
Buchman J, Blair JE (1932) Maggots and their use in the treatment of chronic osteomyelitis. Surg Gynecol Obstet 55:177–190
Cazander G, van Veen KE, Bouwman LH, Bernards AT, Jukema GN (2009) The influence of maggot excretions on PAO1 biofilm formation on different biomaterials. Clin Orthop Relat Res 467:536–545
Cazander G, van de Veerdonk MC, Vandenbroucke-Grauls CM, Schreurs MW, Jukema GN (2010) Maggot excretions inhibit biofilm formation on biomaterials. Clin Orthop Relat Res 468:2789–2796
Ceřovský V, Zdárek J, Fucík V, Monincová L, Voburka Z, Bém R (2010) Lucifensin, the long-sought antimicrobial factor of medicinal maggots of the blowfly Lucilia sericata. Cell Mol Life Sci 67:455–466
Ceřovský V, Slaninová J, Fučík V, Monincová L, Bednárová L, Maloň P, Stokrová J (2011) Lucifensin, a novel insect defensin of medicinal maggots: synthesis and structural study. Chembiochem 12:1352–1361
Chambers L, Woodrow S, Brown AP, Harris PD, Phillipes D, Hall M, Church JCT, Pritchard DI (2003) Degradation of extracellular matrix components by defined proteinases from the greenbottle larva Lucilia sericata used for the clinical debridement of non-healing wounds. Br J Dermatol 148:14–23
Chernin E (1986) Surgical maggots. South Med J 79:1143–1145
Church JCT (1996) The traditional use of maggots in wound healing, and the use of larva therapy (biosurgery) in modern medicine. J Altern Complem Med 2:525–527
Church JCT (1999) Larva therapy in modern wound care: a review. Prim Intent 7:63–68
Contreras-Ruiz J, Fuentes-Suarez A, Karam-Orantes M, MdL E-M, Dominguez-Cherit J (2005) Larval debridement therapy in Mexico. Wound Care Can 3:42–45
Dumville JC, Worthy G, Jm B, Cullum N, Dowson C, Iglesias C, Mitchell JL, Nelson EA, Soares MO, Torgerson DJ, on behalf of the VenUS II team (2009) Larval therapy for leg ulcers (VenUS II): randomised controlled trial. Br Med J 338:1047–1050
Erdmann GR, Khalil SKW (1986) Isolation and identification of two antibacterial agents produced by a strain of Proteus mirabilis isolated from larvae of the screwworm (Cochliomyia hominivorax) (Diptera: Calliphoridae). J Med Entomol 23:208–211
Fine A, Alexander H (1934) Maggot therapy— technique and clinical application. J Bone Joint Surg 16:572–582
Fleischmann W, Grassberger M, Sherman R (2004) Maggot therapy: a handbook of maggot-assisted wound healing, 1st edn. Thieme, Stuttgart
Gilead L, Mumcuoglu K, Ingber A (2012) The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients. J Wound Care 21:78–85
Grantham-Hill C (1933) Preliminary note on the treatment of infected wounds with the larva of Wohlfahrtia nuba. Trans R Soc Trop Med Hyg 27:93–98
Grassberger M, Fleischmann W (2002) The biobag – a new device for the application of medicinal maggots. Dermatology 204:306
Greenberg B (1968) Model for destruction of bacteria in the midgut of blow fly maggots. J Med Entomol 5:31–38
Greenberg B (1973) Flies and disease, vol. 2. Biology and disease transmission. Princeton University Press, Princeton
Horn KL, Cobb AH Jr, Gates GA (1976) Maggot therapy for subacute mastoiditis. Arch Otolaryngol 102:377–379
Horobin AJ, Shakesheff KM, Woodrow S, Robinson C, Pritchard DI (2003) Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon interactions between human dermal fibroblasts and extracellular matrix components. Br J Dermatol 148:923–933
Horobin AJ, Shakesheff KM, Pritchard DI (2005) Maggots and wound healing: an investigation of the effects of secretions from Lucilia sericata larvae upon the migration of human dermal fibroblasts over a fibronectin-coated surface. Wound Repair Regen 13:422–433
Huberman L, Gollop N, Mumcuoglu KY, Block C, Galun R (2007a) Antibacterial properties of whole body extracts and haemolymph of Lucilia sericata maggots. J Wound Care 16:123–127
Huberman L, Gollop N, Mumcuoglu KY, Breuer E, Bhusare SR, Shai Y, Galun R (2007b) Antibacterial substances of low molecular weight isolated from the blowfly, Lucilia sericata. Med Vet Entomol 21:127–131
Jukema GN, Menon AG, Bernards AT, Steenvoorde P, Rastegar AT, van Dissel JT (2002) Amputation-sparing treatment by nature: “surgical” maggots revisited. Clin Infect Dis 35:1566–1571
Kawabata T, Mitsui H, Yokota K, Shino KI, Guma KO, Sano S (2010) Induction of antibacterial activity in larvae of the blowfly Lucilia sericata by an infected environment. Med Vet Entomol 24:375–381
Kerridge A, Lappin-Scott H, Stevens JR (2005) Antibacterial properties of larval secretions of the blowfly, Lucilia sericata. Med Vet Entomol 19:333–337
Kingu HJ, Kuria SK, Villet MH, Mkhize JN, Dhaffala A, Iisa JM (2012) Cutaneous myiasis: is Lucilia cuprina safe and acceptable for maggot debridement therapy? J Cosmet Dermatol Sci Appl 2:79–82
Kruglikova AA, Chernysh SI (2011) Antimicrobial compounds from the excretions of surgical maggots, Lucilia sericata (Meigen) (Diptera, Calliphoridae). Entomol Rev 91:813–819
Leclercq M (1990) Utilisation de larves de Dipteres – maggot therapy – en medicine: historique et actualite. Bull Annls Soc belge Entomol 126:41–50
Livingston SK, Prince LH (1932) The treatment of chronic osteomyelitis with special reference to the use of the maggot active principle. J Am Med Assoc 98:1143–1149
Markevich YO, McLeod-Roberts J, Mousley M, Melloy E (2000) Maggot therapy for diabetic neuropathic foot wounds: a randomized study. In: Abstract of the 59th European association for the study of diabetes, Jerusalem, 17–21 September 2000
McClellan NW (1932) The maggot treatment of osteomyelitis. Can Med Assoc J 27:256–260
Messer FC, McClellan RH (1935) Surgical maggots. A study of their functions in wound healing. J Lab Clin Med 20:1219–1226
Mumcuoglu KY (2001) Clinical applications for maggots in wound care. Am J Clin Dermatol 2:219–227
Mumcuoglu KY, Lipo M, Ioffe-Uspensky I, Miller J, Galun R (1997) Maggot therapy for gangrene and osteomyelitis (in Hebrew). Harefuah 132:323–325, 382
Mumcuoglu KY, Ingber A, Gilead L, Stessman J, Friedman R, Schulman H, Bichucher H, Ioffe-Uspensky I, Miller J, Galun R, Raz I (1998) Maggot therapy for the treatment of diabetic foot ulcers. Diabetes Care 21:2030–2031
Mumcuoglu KY, Ingber A, Gilead L, Stessman J, Friedmann R, Schulman H, Bichucher H, Ioffe-Uspensky I, Miller J, Galun R, Raz I (1999) Maggot therapy for the treatment of intractable wounds. Int J Dermatol 8:623–627
Mumcuoglu KY, Miller J, Mumcuoglu M, Friger M, Tarshis M (2001) Destruction of bacteria in the digestive tract of the maggot of Lucilia sericata (Diptera: Calliphoridae). J Med Entomol 38:161–166
Mumcuoglu KY, Davidson E, Avidan A, Gilead L (2012) Pain related to maggot debridement therapy. J Wound Care 21:400, 402, 404–405
Namias NN, Varela E, Varas RP, Quintana O, Ward CG (2000) Biodebridement: a case report of maggot therapy for limb salvage after fourth-degree burns. J Burn Care Rehabil 21:254–257
Nigam Y, Bexfield A, Thomas S, Ratcliffe NA (2006a) Maggot therapy: the science and implication for CAM. Part I—history and bacterial resistance. eCAM 3:223–227
Nigam Y, Bexfield A, Thomas S, Ratcliffe NA (2006b) Maggot therapy: the science and implication for CAM. Part II—maggots combat infection. eCAM 3:303–308
Nigam Y, Dudley E, Bexfield A, Bond AE, Evans J, James J (2010) The physiology of wound healing by the medicinal maggot, Lucilia sericata. Adv Insect Physiol 39:39–81
Nuesch R, Rahm G, Rudin W, Steffen I, Frei R, Rufli T, Zimmerli W (2002) Clustering of bloodstream infections during maggot debridement therapy using contaminated larvae of Protophormia terraenovae. Infection 30:306–309
Paul AG, Ahmad NW, Lee HL, Ariff AM, Saranum M, Naicker AS, Osman Z (2009) Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers. Int Wound J 6:39–46
Pavillard ER, Wright EA (1957) An antibiotic from maggots. Nature 180(4592):916–917
Pechter EA, Sherman RA (1983) Maggot therapy: the surgical metamorphosis. Plast Reconstr Surg 72:567–570
Peck GW, Kirkup BC (2012) Biocompatibility of antimicrobials to maggot debridement therapy: medical maggots Lucilia sericata (Diptera: Calliphoridae) exhibit tolerance to clinical maximum doses of antimicrobials. J Med Entomol 49:1137–1143
Prete PE (1997) Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. Life Sci 60:505–510
Pritchard DI, Telford G, Diab M, Low W (2012) Expression of a cGMP compatible Lucilia sericata insect serine proteinase debridement enzyme. Biotechnol Prog 28:567–572
Reames MK, Christensen C, Luce EA (1988) The use of maggots in wound debridement. Ann Plast Surg 21:388–391
Robinson W (1933) The use of blowfly larvae in the treatment of infected wounds. Ann Entomol Soc Am 26:270–276
Robinson W (1935a) Progress of maggot therapy in the United States and Canada in the treatment of suppurative diseases. Am J Surg 29:67–71
Robinson W (1935b) Stimulation of healing in non-healing wounds: by allantoin occurring in maggot secretions and of wide biological distribution. J Bone Joint Surg Am 17:267–271
Robinson W, Baker FL (1939) The enzyme urease and occurrence of ammonia in maggot infected wounds. J Parasitol 25:149–155
Robinson W, Norwood VH (1933) The role of surgical maggots in the disinfection of osteomyelitis and other infected wounds. J Bone Joint Surg 15:409–412
Robinson W, Norwood VH (1934) Destruction of pyogenic bacteria in the alimentary tract of surgical maggots implanted in infected wounds. J Lab Clin Med 19:581–586
Sherman RA (1997) A new dressing design for use with maggot therapy. Plast Reconstr Surg 100:451–456
Sherman RA (2002a) Maggot therapy for foot and leg wounds. Int J Low Extrem Wounds 1:135–142
Sherman RA (2002b) Maggot versus conservative debridement therapy for the treatment of pressure ulcers. Wound Repair Regen 10:208–214
Sherman RA (2003) Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy. Diabetes Care 26:446–451
Sherman RA, Shimoda KJ (2004) Presurgical maggot debridement of soft tissue wounds is associated with decreased rates of postoperative infection. Clin Infect Dis 39:1067–1070
Sherman RA, Wyle FA, Thrupp L (1995a) Effects of seven antibiotics on the growth and development of Phaenicia sericata (Diptera: Calliphoridae) larvae. J Med Entomol 32:646–649
Sherman RA, Wyle F, Vulpe M (1995b) Maggot therapy for treating pressure ulcers in spinal cord injury patients. J Spinal Cord Med 18:71–74
Sherman RA, Tran JM-T, Sullivan R (1996) Maggot therapy for venous stasis ulcers. Arch Dermatol 132:254–256
Sherman RA, Hall MJ, Thomas S (2000) Medicinal maggots: an ancient remedy for some contemporary afflictions. Annu Rev Entomol 45:55–81
Sherman RA, Sherman JM-T, Gilead L, Lipo M, Mumcuoglu KY (2001) Maggot debridement therapy in outpatients. Arch Phys Med Rehabil 82:1226–1229
Sherman RA, Morrison S, Ng D (2007a) Maggot debridement therapy for serious horse wounds – a survey of practitioners. Vet J 174:86–91
Sherman RA, Shapiro CE, Yang RM (2007b) Maggot therapy for problematic wounds: uncommon and off-label applications. Adv Skin Wound Care 20:602–610
Sherman RA, Stevens H, Ng D, Iversen E (2007c) Treating wounds in small animals with maggot debridement therapy: a survey of practitioners. Vet J 173:138–143
Simmons SW (1935) A bactericidal principle in excretions of surgical maggots which destroys important etiological agents of pyogenic infections. J Bacteriol 30:253–267
Steenvoorde P, Oskam J (2005) Bleeding complications in patients treated with maggot debridement therapy. Int J Low Extrem Wounds 4:57–58
Steenvoorde P, Budding T, Oskam J (2005a) Determining pain levels in patients treated with maggot debridement therapy. J Wound Care 14:485–488. Erratum in J Wound Care 2006 15:71
Steenvoorde P, Budding TJ, van Engeland A, Oskam J (2005b) Maggot therapy and the “Yuk” factor: an issue for the patient? Wound Repair Regen 13:350–352
Steenvoorde P, Jacobi CE, Oskam J (2005c) Maggot debridement therapy: free-range or contained? An in-vivo study. Adv Skin Wound Care 18:430–435
Tantawi TI, Gohar YM, Kotb MM, Beshara FM, El-Naggar MM (2007) Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers. J Wound Care 16:379–383
Tantawi TI, Williams KA, Villet MH (2010) An accidental but safe and effective use of Lucilia cuprina (Diptera: Calliphoridae) in maggot debridement therapy in Alexandria, Egypt. J Med Entomol 47:491–494
Teich S, Myers RAM (1986) Maggot therapy for severe skin infections. South Med J 79:1153–1155
Telford G, Brown AP, Rich A, English JS, Pritchard DI (2012) Wound debridement potential of glycosidases of the wound-healing maggot, Lucilia sericata. Med Vet Entomol 26:291–299
Thomas S (2006) Costs of managing chronic wounds in the UK, with particular emphasis on maggot debridement therapy. J Wound Care 15:465–469
Thomas S, Jones M, Shutler S, Jones S (1996) Using larvae in modern wound management. J Wound Care 5:60–69
Thomas S, Andrews AM, Hay NP, Bourgoise S (1999) The anti-microbial activity of maggot secretions: results of a preliminary study. J Tissue Viability 9:127–132
Thomas S, Wynn K, Fowler T, Jones M (2002) The effect of containment on the properties of sterile maggots. Br J Nurs 11:S21–S28
Vistnes LM, Lee R, Ksander GA (1981) Proteolytic activity of blowfly larvae secretions in experimental burns. Surgery 90:835–841
Wayman J, Nirojogi V, Walker A, Sowinski A, Walker MA (2001) The cost effectiveness of larval therapy in venous ulcers. J Tissue Viability 10:91–94
Whitaker IS, Twine C, Whitaker MJ, Welck M, Brown CS, Shandall A (2007) Larval therapy from antiquity to the present day: mechanisms of action, clinical applications and future potential. Postgrad Med J 83:409–413
Wolff H, Hansson C (2003) Larval therapy– an effective method of ulcer debridement. Clin Exp Dermatol 28:134–137
Wollina U, Liebold K, Schmidt WD, Hartmann M, Fassler D (2002) Biosurgery supports granulation and debridement in chronic wounds – clinical data and remittance spectroscopy measurement. Int J Dermatol 41:635–639
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Sherman, R.A., Mumcuoglu, K.Y., Grassberger, M., Tantawi, T.I. (2013). Maggot Therapy. In: Grassberger, M., Sherman, R., Gileva, O., Kim, C., Mumcuoglu, K. (eds) Biotherapy - History, Principles and Practice. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6585-6_2
Download citation
DOI: https://doi.org/10.1007/978-94-007-6585-6_2
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6584-9
Online ISBN: 978-94-007-6585-6
eBook Packages: MedicineMedicine (R0)